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Ifr1Although infection of mouse embryoﬁbroblasts (MEFs) with WNV Eg101 induced interferon (IFN) beta pro-
duction and STAT1 and STAT2 phosphorylation, these transcription factors (TFs) were not detected in the nu-
cleus or on the promoters of four IRF-3-independent interferon stimulated genes (ISGs): Oas1a and Irf7
(previously characterized as IFN/ISGF3-dependent), Oas1b and Irf1. These ISGs were upregulated in WNV
Eg101-infected STAT1−/−, STAT2−/−, and IFN alpha/beta receptor−/− MEFs. Although either IRF-3 or
IRF-7 could amplify/sustain Oas1a and Oas1b upregulation at later times after infection, these factors were
not required for the initial gene activation. The lack of upregulation of these ISGs in WNV Eg101-infected
IRF-3/9−/− MEFs suggested the involvement of IRF-9. Activation of Irf1 in infected MEFs did not depend
on any of these IRFs. The data indicate that additional alternative activation mechanisms exist for subsets
of ISGs when a virus infection has blocked ISG activation by the canonical IFN-mediated pathway.
© 2012 Elsevier Inc. All rights reserved.Introduction
The family Flaviviridae, genus Flavivirus, contains several human
pathogens including West Nile virus (WNV), dengue virus, yellow
fever virus (YFV), Japanese encephalitis virus (JEV) and tick borne en-
cephalitis virus (TBEV). WNV is a mosquito-borne virus that is trans-
mitted in a bird–mosquito cycle but occasionally mammals including
humans and horses are infected. WNV infections in humans are usu-
ally asymptomatic but can induce a mild febrile illness; however,
some patients develop encephalitis or a poliomyelitis-like disease.
WNV particles contain a single-stranded, positive-sense RNA genome
encoding a single polyprotein that is cleaved by viral and cellular pro-
teases into three structural and seven nonstructural proteins
(Brinton, 2002). WNV isolates have been divided into two main line-
ages. Lineage I strains are often associated with outbreaks of human
disease, while the majority of lineage II strains are non-emerging
and cause zoonotic infections in Africa (Brinton, 2002).
IFNs were ﬁrst discovered as cytokines that inhibit viral replication
(Isaacs and Lindenmann, 1957). Induction of type I IFNs is primarily trig-
gered by pattern recognition receptors (PRRs) that recognize viral
nucleic acids. Viral double stranded RNA (dsRNAs) or single stranded
RNAs (ssRNAs) are recognized by cytoplasmic PRRs, such as retinoicorgia State University, P.O. Box
301.
rights reserved.acid inducible gene-I (RIG-I) and melanoma differentiation antigen 5
(MDA5), or by cell surface and endosomal PRRs, such as Toll-like recep-
tor 3 (TLR-3), TLR7 and TLR-8 (Saito andGale, 2007). Recognition of viral
nucleic acids by these PRRs leads to activation of the TFs, IRF-3, NF-
kappa B and ATF2/c-Jun (AP1), that assemble on the IFN-beta promoter
and activate IFN-beta gene expression (Merika and Thanos, 2001). Se-
creted IFN beta binds to cell surface IFN alpha/beta receptor (IFN
alpha/beta R) complexes inducing activation of receptor-associated Jak
kinases followed by recruitment and phosphorylation of the TFs,
STAT1 and STAT2. STAT1, STAT2 and IFN regulatory factor-9 (IRF-9)
form a trimeric transcription factor complex referred to as IFN stimulat-
ed gene factor 3 (ISGF3) that translocates to the nucleus and binds to
IFN-stimulated response elements (ISREs) in the promoters of IFN-
stimulated genes (ISGs) (Stark et al., 1998). The induction of IFN beta
is biphasic due to the induction of ISGs, such as IRF-7, which enhance
IFN beta gene expression and sustain ISG production. IRF-7 also induces
the expression of IFN-alphawhich ampliﬁes the type I IFN response via a
positive feedback loop (Marie et al., 1998; Sato et al., 2000).
The expression of IFN beta and multiple interferon stimulated
genes (ISGs), some of which have identiﬁed antiviral functions, repre-
sents the ﬁrst line of defense against a viral infection. Many viruses
suppress the innate immune response by blocking the Jak-STAT sig-
naling pathway. Different ﬂaviviruses were reported to block this
pathway by either inhibiting Jak phosphorylation (Best et al., 2005;
Guo et al., 2005; Ho et al., 2005; Lin et al., 2004), reducing the expres-
sion of STAT2 (Jones et al., 2005; Mazzon et al., 2009) or blocking
STAT1 and STAT2 phosphorylation (Best et al., 2005; Liu et al., 2005;
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NY99 were previously shown to effectively block STAT1 phosphoryla-
tion in primate cells (Keller et al., 2006; Laurent-Rolle et al., 2010; Liu
et al., 2005). In contrast, WNV Eg101, a lineage I stain closely related
to NY99 but less neuroinvasive (Beasley et al., 2002) was previously
reported not to inhibit STAT1 phosphorylation in mouse cells
(Scherbik et al., 2006, 2007). However, the effects of WNV Eg101 in-
fection on STAT2 phosphorylation and ISGF3 nuclear translocation
in these cells were not investigated.
Inhibition of the Jak-STAT signaling pathway by a viral infection
would be expected to suppress ISG expression which is required for
the establishment of an effective cellular antiviral response. However,
even though ISGs were ﬁrst described as IFN-induced genes, some
were subsequently shown to be upregulated by viral infections in
an IFN-independent manner through recognition of viral components
by PRRs and activation of constitutively expressed TFs such as IRF-3
and NF-kappa B (Andersen et al., 2008; Basagoudanavar et al., 2011;
Elco et al., 2005; Grandvaux et al., 2002; Nakaya et al., 2001; Peters
et al., 2002). Subsequent upregulation of additional TFs, such as IRF-
7, was also shown to play a role in the expression of some ISGs in
infected cells (Barnes et al., 2004). IRF-7 and IRF-3 were previously
reported to be important for IFN production and protection against
WNV (Dafﬁs et al., 2007, 2008; Fredericksen et al., 2004).
Due to the high degree of homology between the ISRE and IRF
binding element (IRF-E) consensus sequences, the ISREs of some
ISGs can be directly induced by either IRF-3 or IRF-7 (Lin et al.,
2000; Morin et al., 2002; Schmid et al., 2010). In MEFs, Irf7 gene ex-
pression must ﬁrst be induced and then IRF-7 has to be activated be-
fore this TF can directly upregulate a subset of ISGs (Barnes et al.,
2004). In contrast, IRF-3 is a constitutively expressed protein that is
in the cytoplasm of all cells in an inactive form. IRF-3 activation is
mediated by phosphorylation at multiple C terminal serine and thre-
onine residues. Phosphorylation-induced dimerization leads to nucle-
ar translocation of IRF-3 in a complex with histone acetyltransferases
p300 and CREB-binding protein (CBP) (Fitzgerald et al., 2003; Sharma
et al., 2003; Suhara et al., 2002; Yoneyama et al., 1998). The results of
an analysis of murine ISG expression during a Newcastle disease virus
(NDV) infection in IRF-3−/− MEFs led to the classiﬁcation of ISGs
such as ISG15, ISG54, IP-10 and GBP as genes activated in an IRF-3-
dependent manner and ISGs such as Oas1a and Irf7 as genes upregu-
lated in an IRF-3-independent but IFN-dependent manner through
activation of the ISGF3 transcription factor complex (Nakaya et al.,
2001). A more recent analysis of ISG expression in IRF-3−/− MEFs
infected with NDV conﬁrmed that the expression of Oas1a and Irf7
did not depend on IRF-3 and showed that this was also the case for
the Oas1b and Irf1 genes (Andersen et al., 2008).
NF-kappa B exists in the cytoplasm in an inactive form in a complex
with an inhibitory I kappa B protein (Whiteside and Israel, 1997). Acti-
vation of the NF-kappa B pathway by viral infection upregulates the ex-
pression of a speciﬁc subset of ISGs encoding cytokines and chemokines,
such as RANTES, TNF alpha and others, regulators of apoptosis and TFs,
including A20, Irf1 and Irf2 and others (Elco et al., 2005; Pahl, 1999).
The murine 2′–5′ oligoadenylate synthetase 1a (Oas1a) and Oas1b
genes are ISGs that have antiviral functions. Oas1a is an enzymatically
active synthetase that upon binding to viral dsRNA synthetizes 2′–5′-
oligoadenylates (2–5A) from ATP which activate the latent endonu-
clease RNase L. Activated RNase L degrades both cellular and viral
single-stranded RNAs (Samuel, 2001). Oas1b is an inactive synthetase
that mediates resistance to ﬂavivirus-induced disease through an
unknown RNase L independent mechanism (Scherbik et al., 2006).
Oas1b was also reported to inhibit in vitro Oas1a synthetase activity
in a dose-dependent manner (Elbahesh et al., 2011). Another study
showed that IFN beta activation of Oas1a expression was STAT1-
and STAT2-dependent while that of Oas1b was STAT1-independent
and STAT2-dependent indicating that these two duplicated genes
are differentially regulated by IFN beta (Pulit-Penaloza et al., 2012).WNV Eg101 infection in MEFs was previously reported to activate
IFN beta expression, induce STAT1 Tyr701 phosphorylation and upre-
gulate the expression of Oas1a, Oas1b as well as other ISGs including
Irf7 and Irf1 (Scherbik et al., 2006, 2007). However, whether the
upregulation of these IRF-3-independent ISGs in WNV-infected MEF
is mediated by IFN or by an alternative virus-activated pathway was
not previously analyzed.
Although IFN beta expression is upregulated and STAT1 and STAT2
are phosphorylated in WNV Eg101 infected MEF, the present study
showed that nuclear translocation of these TFs was blocked. Consis-
tent with this observation, no increase in the binding of either
STAT1 or STAT2 to the Oas1a, Oas1b or Irf7 promoters or of STAT1
to the Irf1 promoter was observed even though these ISGs were upre-
gulated. Each of these genes was also upregulated by WNV Eg101 in-
fection in STAT1−/−, STAT2−/− and IFN alpha/beta R−/− MEFs
indicating that these ISGs were not upregulated by the canonical
type 1 IFN-mediated Jak-STAT pathway or by an alternative IFN
alpha/beta R-mediated signaling pathway. Oas1a, Oas1b and Irf7
were also upregulated in infected IRF-3−/−, IRF-7−/−MEFs and ini-
tially in IRF-3/7−/−MEFs but not in infected IRF-3/9−/−MEFs sug-
gesting the involvement of IRF-9. Either IRF-3 or IRF-7 could enhance
Oas1a and Oas1b upregulation at later times after infection. Activation
of Irf1 in infected MEFs did not depend on any of these IRFs. The data
support the existence of alternative mechanisms of ISG upregulation
when the canonical type I IFN pathway is blocked by a WNV infection.
Results
The kinetics of IFN beta expression, secretion and signaling in WNV
Eg101-infected MEFs
Previous studies reported increased STAT1 phosphorylation as well
as increased expression of many ISGs, including Oas1a, Oas1b, Irf1 and
Irf7 in WNV Eg101-infected MEFs (Scherbik et al., 2006, 2007). To de-
termine whether ISG expression in WNV Eg101-infected MEFs is tem-
porally related to the induction of IFN beta, the kinetics of IFN beta
expression in WNV Eg101 infected [multiplicity of infection (MOI) of
5], transformed C3H/He (tC3H/He) MEFs were analyzed by real time
qRT-PCR. IFN beta mRNA levels in tC3H/He MEFs were elevated by 10
fold at 6 h, by 100 fold at 12 h and by more than 5000 fold at 24 and
48 h after WNV Eg101 infection (Fig. 1A). The results obtained were
similar to those previously reported for infected primary C3H/He
(pC3H/He) MEFs (Scherbik et al., 2006). Analysis of extracellular IFN
beta protein levels with an enzyme-linked immunosorbent assay
(ELISA) detected low levels of IFN beta at 16 h after WNV Eg101 infec-
tion of tC3H/He MEFs that continued to increase through 48 h
(Fig. 1B). At 48 h, 860 pg/ml of IFN beta was detected which corre-
sponds to about 730 International units/ml based on ELISA data
obtained with standard curves done on dilutions of an IFN beta sample
of known unit concentration. Similar IFN levels were previously
reported for WNV infected primary MEFs (Dafﬁs et al., 2009).
The binding of IFN beta to its cell surface receptor results in activa-
tion of the Jak-STAT signaling pathway and phosphorylation of STAT1
and STAT2. A previous study showed that robust phosphorylation of
STAT1 occurred in primary C3H/He MEFs after infection with WNV
Eg101 (Scherbik et al., 2007). To determine whether this was also
the case in transformed MEFs, activation of the Jak-STAT signaling
pathway in tC3H/He MEFs by either IFN beta treatment or WNV
Eg101-infection was analyzed by Western blotting. Increased levels
of both total and phospho-STAT1 as well as of total and phospho-
STAT2 were observed after a 3 h incubation of cells with murine IFN
beta (Fig. 1C). Upregulation of total STAT1 and STAT2 levels was
also observed from 12 h through 48 h after WNV Eg101 infection.
Low levels of phosphorylated STAT1 (Tyr 701) were detected at 2, 6
and 12 h after infection, while robust phosphorylation was seen at
24 and 48 h. Low levels of STAT2 phosphorylation (Tyr 690) were
Fig. 1. IFN beta is produced byWNV Eg101 infected MEFs and induces phosphorylation of STAT1 and STAT2. MEFs were mock-infected or infected with WNV Eg101 at a MOI of 5 for
the indicated times or treated with 1000 U/ml of murine IFN beta for 3 h. (A) Total RNA from tC3H/He MEFs was extracted and IFN beta mRNA levels were assayed by real-time qRT-
PCR. (B) Extracellular IFN beta protein levels in tC3H/He MEF culture ﬂuid were assayed by ELISA. The values shown are averages from at least two independent experiments per-
formed in duplicate. The bars represent ±SD. (C) tC3H/He cell lysates were analyzed by Western blotting using antibodies speciﬁc for the indicated proteins. Actin was used as the
loading control. The blots shown are representative of results obtained from three independent experiments. (D) and (E) Comparison of ISG activation by IFN beta in primary and
transformed MEFs. Total RNA was extracted from (D) tC3H/He or (E) pC3H/He MEFs infected with WNV Eg101 (MOI 5) for the indicated times, mock-infected or treated with mu-
rine IFN beta (1000 U/ml) for 3 h. The changes in the levels of Oas1a and Oas1b mRNA were assessed by real-time qRT-PCR. For (A),(D), and (E), each experiment was performed in
triplicate and representative data from one of two or three independent experiments are shown. The mRNA level of each gene was normalized to the level of GAPDH mRNA in the
same sample and is shown as the fold change over the amount of mRNA in mock samples expressed in relative quantiﬁcation units (RQUs). The error bars represent the calculated
SE (n=3) and are based on an RQMin/Max of the 95% conﬁdence level.
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after infection but not at 48 h. IRF-9 upregulation was detected as
early as 6 h and was robust by 24 h after infection and also after a
3 h incubation with IFN beta. Viral NS3 protein levels were analyzed
to estimate the efﬁciency of the viral infection. NS3 was detected by
12 h after infection and the levels increased at both 24 and 48 h
(Fig. 1C). The results indicated that upregulation of IFN beta produc-
tion and its activation of the Jak-STAT signaling pathway began
early in WNV Eg101-infected MEFs and continued throughout the in-
fection. Although WNV Eg101 infection induced STAT1 and STAT2
phosphorylation in murine cells, infection of A549 (human) or
MA104 (African green monkey) cells with this virus did not result
in STAT phosphorylation (data not shown) similar to what was previ-
ously reported for other lineage I WNV strain infections in primate
cells (Keller et al., 2006; Laurent-Rolle et al., 2010; Liu et al., 2005).
Comparison of Oas1a, Oas1b, Irf7 and Irf1 expression levels in primary
and transformed C3H/He MEFs infected with WNV Eg101
It was previously reported that transformed cells respond to IFNbeta
treatment but that the levels of ISG upregulation are lower in these cells
compared to those in primary cells (Bartee and McFadden, 2009). Since
both primary and transformed MEFs were used in this study, IFN-
induced ISG upregulation in tC3H/He (Fig. 1D) and pC3H/He (Fig. 1E)
MEFs was compared. The four ISGs analyzed, Oas1a, Oas1b, Irf7 and
Irf1, were upregulated in both types of cells by IFN beta-treatment andWNV Eg101-infection. However, consistent with the previous report,
higher levels of ISG induction by both IFN and virus were observed in
infected primary MEFs than in transformed MEFs.
Association of STAT1 and STAT2 with ISG promoters in WNV Eg101-
infected MEFs
The observation that STAT1 and STAT2were phosphorylated inWNV
Eg101-infected MEFs suggested that upregulation of the Oas1a, Oas1b,
Irf7 and Irf1 genes might be mediated by the canonical type I IFN path-
way. The Oas1a and Oas1b promoters each contain a canonical ISRE
(Pulit-Penaloza et al., 2012), Irf7 contains an inverted ISRE (Ning et al.,
2005; Schmid et al., 2010) and the Irf1 promoter has a GAS element in-
stead of an ISRE which is upregulated in IFN-stimulated cells by a
STAT1 dimer (Pine et al., 1994). STAT1 and STAT2 occupancy on the
Oas1a, Oas1b and Irf7 promoters and STAT1 occupancy on the Irf1 pro-
moter in vivo were analyzed with a chromatin immunoprecipitation
(ChIP) assay done as described in Materials and methods using tC3H/
He MEFs that were mock-infected, infected with WNV Eg101 (MOI of
5) for 7, 16 or 24 h or treated with 1000 U/ml of murine IFN beta for
30 m. Brieﬂy, in vivo crosslinkedDNA–protein complexeswere immuno-
precipitated using anti-STAT1, anti-STAT2 or a nonspeciﬁc IgG antibody.
After reversing the crosslinks, immunoprecipitated DNA was puriﬁed
and quantiﬁed by real-time qPCR. An increase in STAT1 (Fig. 2A) and
STAT2 (Fig. 2B) promoter binding compared to that in untreated cells
was detected for Oas1a, Oas1b and Irf7 in cells treated with IFN beta. In
Fig. 2. STAT1 and STAT2 translocation to the nucleus is inhibited in WNV Eg101-infected MEFs. A chromatin immunoprecipitation assay (ChIP) assessed binding (A) of STAT1 to the
Oas1a, Oas1b, Irf7 and Irf1 promoters and (B) of STAT2 to the Oas1a, Oas1b and Irf7 promoters in vivo. The amount of precipitated Oas1a and Oas1b promoter DNAwas quantiﬁed by
real-time qPCR with promoter speciﬁc primers and ﬂuorogenic TaqMan FAM/MGB probes as described in Materials and Methods. Nonspeciﬁc IgG antibody was used as a negative
control. The average values from at least two independent experiments performed in triplicate were plotted and the bars ±SD. Confocal microscopy analyses of STAT2 cellular lo-
calization in (C) tC3H/He MEFs were infected with WNV at a MOI of 5 for the indicated times and (D) tC3H/He MEFs incubated with 1000 U/ml of IFN beta for 30 m at different
times after WNV Eg101 infection. Nuclei were stained with Hoechst dye (blue), STAT2 was detected with anti-STAT2 antibody (green) and infected cells were detected with
anti-dsRNA antibody (red). The results shown are representative of two independent experiments. (E) Quantiﬁcation of the results in panels C and D. The pixel intensity in a rep-
resentative area in the nucleus was measured and divided by the pixel intensity of an area of the same size in the cytoplasm. This measurement was done on 20 cells at each time
and under each condition. The average values were plotted and bars indicate ±SD (n=20). (F) t129 MEFs were mock treated, treated with IFN beta (500 U/ml) for 30 m or infected
with WNV Eg101 at a MOI of 5 for 16 or 24 h. Whole cell lysates were separated into cytoplasmic and nuclear fractions and analyzed by Western blotting using antibodies speciﬁc
for STAT1, STAT2 or histone 3 (H3). H3 was used as a control nuclear protein. The blots shown are representative of the results obtained from two independent experiments.
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ing compared to that inmock infected cells was detected in cells infected
with WNV Eg101 for 7, 16 or 24 h. An increase in STAT1 binding to the
Irf1 promoter was observed in cells treated with IFN but not in cells
infected with WNV Eg101. These results suggested that the nuclear
translocation of phosphorylated STAT1 and STAT2 was blocked in WNVEg101-infected MEF. To test this hypothesis, the kinetics of STAT1 and
STAT2 nuclear translocation in tC3H/He MEFs infected with WNV
Eg101 (MOI of 5) were analyzed by confocal microscopy. Robust STAT2
nuclear translocation, as indicated by STAT2 accumulation in the nucleus,
was detected in IFN beta-treated cells (Fig. 2D top row) but not inmock-
treated cells or cells infected with WNV Eg101 for 8, 16, 24, 32 or 48 h
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STAT1 (data not shown).Westernblotting of cytoplasmic andnuclear cell
fractions from infected and IFN-treated t129 MEFs cells conﬁrmed the
lack of STAT1 and STAT2 nuclear accumulation in infected MEFs of a dif-
ferent genetic background (Fig. 2F). Similar Western results were
obtained with tC3H/He MEFs (data not shown). To test whether a WNV
Eg101 infection could block STAT2 nuclear translocation mediated by
the addition of exogenous IFN beta, tC3H/He MEFs infected with WNV
Eg101 for 8, 16, 24, 32 or 48 h were incubated with murine IFN beta
(1000 U/ml) for 30 m before ﬁxing the cells. In mock-infected cells and
cells infected for 8 h (a timewhen viral dsRNA is not yet detectable by im-
munoﬂuorescence; Fig. 2C second row), the addition of IFN beta resulted
in detectable STAT2 nuclear translocation (Fig. 2D second row). In con-
trast, nuclear translocation of STAT2 was not observed when IFN beta
was added to cells infected for 16, 24, 32 or 48 h (Fig. 2D). Even though
STAT1 and STAT2 were phosphorylated in WNV Eg101 infected MEFs,
nuclear localization of these TFs was blocked which is typical of lineage
I WNV strains (Keller et al., 2006; Laurent-Rolle et al., 2010).
Expression of ISGs in WNV Eg101-infected tSTAT1−/− and tSTAT2−/−
MEFs
The ChIP and nuclear translocation assay results indicated that
upregulation of Oas1a, Oas1b, Irf7 and Irf1 gene expression in WNVFig. 3. Oas1a, Oas1b, Irf7 and Irf1 gene expression is induced in WNV Eg101-infected tSTAT1−
mRNA expression levels in t129, tSTAT1−/− and tSTAT2−/− MEF cell lines was assayed
mock-treated tSTAT1−/− and tSTAT2−/− MEFs, the expression of Oas1a was normalized
and representative data from one of two or three independent experiments are shown. The
and is shown as the fold change over the amount of mRNA in mock samples expressed in RQ
the 95% conﬁdence level. (E) Culture ﬂuid samples harvested at the indicated times after in
duplicate titrations from at least two experiments. Bars indicate ±SD. (F) t129 and tSTAT2
the indicated proteins. Actin was used as the loading control. The blots shown are represenEg101-infected MEFs was mediated in a STAT1- and STAT2-
independent manner. As an additional means of conﬁrming this, the
expression of these four ISG was analyzed by real time qRT-PCR in
tSTAT1−/− and tSTAT2−/− MEFs and matched control wild type
t129 MEFs that were mock-infected, infected with WNV Eg101
(MOI of 5) or treated with murine IFN beta (1000 U/ml) for 3 h. A
10-fold or greater increase in Oas1a, Oas1b and Irf7 mRNA levels
was observed in wild type t129 MEFs stimulated with IFN beta for
3 h or infected with WNV Eg101 for 32 h (Figs. 3A, B and C). Consis-
tent with previous observations (Ousman et al., 2005; Pulit-
Penaloza et al., 2012), no upregulation of Oas1a was detected after
stimulation with IFN beta in either tSTAT1−/− or tSTAT2−/− MEFs
(Fig. 3A), while IFN beta upregulated Oas1b (Fig. 3B) and Irf7
(Fig. 3C) in tSTAT1−/− but not in tSTAT2−/− MEFs. In contrast to
the tSTAT1- and tSTAT2-dependence of Oas1a upregulation by IFN
beta, Oas1a mRNA was detected at 8 h and increased by more than
50 fold by 32 h after WNV infection in both tSTAT1−/− and
tSTAT2−/− MEFs (Fig. 3A). Oas1b mRNA levels increased by about
3-fold at 16 h and by about 300-fold at 32 h after infection in
tSTAT1−/− MEFs and by about 3-fold at 24 h and by about 20-fold
at 32 h after infection in tSTAT2−/− MEFs. Although the fold increase
observed for Oas1b expression in infected tSTAT2−/−MEFs was lower
than that in tSTAT1−/− MEFs, it was still higher than the 10-fold in-
crease observed in infected control t129 MEFs. In both tSTAT1−/−/− and tSTAT2−/−MEFs. Fold induction of (A) Oas1a, (B) Oas1b, (C) Irf7 and (D) Irf1
by real-time qRT-PCR. Because the expression of Oas1a was not detected (ND) in the
to the 8 h WNV Eg101 sample. Each qRT-PCR experiment was performed in triplicate
mRNA level of each gene was normalized to the level of GAPDH mRNA in that sample
Us. The error bars represent the calculated SE (n=3) and are based on an RQMin/Max of
fection were assayed for infectivity by plaque assay. Each data point is the average of
−/− MEF cell lysates were analyzed by Western blotting using antibodies speciﬁc for
tative of results obtained from two independent experiments.
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16 h after infection. Although a 60-fold increase in Irf7 expression
was observed in both wild type t129 and tSTAT1−/− MEFs by 32 h
after infection, only a 10-fold increase in Irf7 mRNA levels was ob-
served in infected tSTAT2−/− MEFs by this time. No upregulation
of Irf-1 after stimulation with IFN beta was observed in either
tSTAT1−/− or tSTAT2−/− MEFs similar to what was observed
with Oas1a. A signiﬁcant increase in Irf1 mRNA levels was observed
in both tSTAT1−/− and tSTAT2−/−MEFs at 24 h after infection but
these levels were lower compared to those in the control t129 MEFs.
However, by 32 h, the levels of Irf1 mRNA were the same in the con-
trol and both types of knockout cells (Fig. 3D). Virus yields from
tSTAT1−/− and tSTAT2−/− MEFs were initially higher than those
from t129 control cells but each of these cell types produced a
peak titer of about 107 PFU/ml by 32 h after infection (Fig. 3E).
IRF-3 was previously reported to be activated by 16 h after a WNV
Eg101 infection in pC3H/He MEFs indicating virus activation of cyto-
plasmic PRRs (Scherbik et al., 2007). The activation of IRF-3 was com-
pared in t129 and tSTAT2−/− MEFs by Western blotting using
antibodies against total IRF-3 and IRF-3 phosphorylated on Ser396.
Phosphorylated IRF-3 was detected at 24 and 32 h after WNV Eg101
infection in control t129 MEFs and at 16, 24 and 32 h in tSTAT2−/−
MEFs (Fig. 3F). Although earlier and more robust activation of IRF-3
was observed in tSTAT2−/− MEFs compared to wild type MEFs, the
level of ISG upregulation was lower in these cells.Fig. 4. Oas1a, Oas1b, Irf7 and Irf1 are induced in a type I IFN independent manner in MEFs
mRNA expression levels in p129 and pIFN alpha/beta R−/− MEFs was assayed by real-
mRNA in the same sample and is shown as the fold change over the amount of mRNA in
(ND) in the mock-, IFN alpha- or IFN beta-treated pIFN alpha/beta R−/− cells, Oas1a expres
iment was performed in triplicate and representative data from one of two or three indepen
based on an RQMin/Max of the 95% conﬁdence level. (E) Culture ﬂuid harvested at the indicat
the average of duplicate titrations from at least two experiments. Bars indicate ±SD.Analysis of the dependence of Oas1a, Oas1b, Irf7 and Irf1 expression in
WNV Eg101-infected MEFs on alternative signaling pathways activated
by the IFN alpha/beta receptor
In addition to activation of the Jak-STAT pathway, type I IFN bind-
ing to the IFN alpha/beta R has also been reported to activate the PI3K
(Kaur et al., 2005) and p38 mitogen-activated protein kinase (MAPK)
signaling pathways (Katsoulidis et al., 2005). Although the results de-
scribed above indicate that the Jak-STAT pathway is not involved in
the upregulation of the ISGs analyzed in WNV Eg101-infected MEFs,
the involvement of an alternative signaling cascade induced by type
I IFN had not been ruled out. To determine whether the upregulation
of the Oas1a, Oas1b, Irf7 and Irf1 genes in WNV Eg101-infected MEFs
was mediated by type 1 IFN alpha/beta R signaling through an alter-
native pathway, the expression of these genes was analyzed in pIFN
alpha/beta R−/− MEFs infected with WNV Eg101 (MOI of 5) by
real time qRT-PCR. All four of the ISGs were upregulated in control
p129 MEFs treated with either universal type I IFN (human IFN
alpha) or murine IFN beta or infected with WNV Eg101 (Figs. 4A, B,
C and D). Because primary 129 MEFs were used for these experi-
ments, the level of gene upregulation was higher than that in the
transformed 129 MEFs used for the experiments shown in Fig. 3. As
expected, no increase in Oas1a, Oas1b, Irf7 or Irf1 expression was ob-
served in pIFN alpha/beta R−/− MEFs after IFN alpha or IFN beta
treatment. Consistent with the results obtained with tSTAT1−/−infected with WNV Eg101. Fold increase in (A) Oas1a, (B) Oas1b, (C) Irf7 and (D) Irf1
time qRT-PCR. The mRNA level of each gene was normalized to the level of GAPDH
mock samples expressed in RQUs. Because the expression of Oas1a was not detected
sion in these cells was normalized to the 8 h WNV Eg101 sample. Each qRT-PCR exper-
dent experiments are shown. The error bars represent the calculated SE (n=3) and are
ed times after infection was analyzed for infectivity by plaque assay. Each data point is
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in mock-infected pIFN alpha/beta R−/− MEFs. In contrast to the
lack of upregulation by IFN beta, a signiﬁcant increase in Oas1a,
Oas1b, Irf7 and Irf1 gene expression was observed in pIFN alpha/
beta R−/− MEFs infected with WNV Eg101 for 16, 24 or 32 h.
The upregulation of the Oas1a and Oas1b genes in the infected
pIFN alpha/beta R−/− MEFs was delayed compared to that in
the control MEFs; however, by 24 h after infection the mRNA levels
for both these genes were comparable to those in wild type MEFs.
The activation of Irf7 was delayed and although Irf7 mRNA levels
increased by about 50-fold by 32 h after infection in pIFN alpha/
beta R−/− MEFs, the maximal upregulation was 20 times less ef-
ﬁcient compared to that in the wild type cells (Fig. 4C). Irf1 ex-
pression in the IFN receptor knockout cells was also delayed and
less efﬁcient as compared to that observed in the wild type cells
(Fig. 4D). Similar to what was previously reported for WNV NY
2000 (Dafﬁs et al., 2009), WNV Eg101 replicated more efﬁciently
in IFN alpha/beta R−/− MEFs than in the control MEFs (Fig. 4E).
Analysis of transcription factors regulating ISG expression during WNV
Eg101 infection
To further investigate the role of IRF-3 in upregulating the four
ISGs analyzed in WNV Eg101-infected MEFs, pIRF-3−/− and
matched wild type pC57/BL6 MEFs were infected with WNV Eg101Fig. 5. The expression of Oas1a and Oas1b but not Irf1 and Irf9 is reduced in pIRF-3/7−/−M
sion levels in pC57BL/6, pIRF-3−/−, pIRF-7−/− and pIRF-3/7−/− MEFs was assayed by re
tative data from one of two or three independent experiments are shown. The mRNA level
shown as the fold change over the amount of mRNA in mock samples expressed in RQU. T
95% conﬁdence level. (F) Culture ﬂuid harvested at the indicated times after infection was
trations from at least two experiments. Bars indicate ±SD.(MOI 5) and the Oas1a, Oas1b, Irf7 and Irf1 mRNA levels were assayed
by real time qRT-PCR. The Oas1a, Oas1b and Irf7 genes were efﬁcient-
ly upregulated in IRF-3−/− and control cells by both IFN beta and
WNV infection (Figs. 5A, B and C). Similarly, the Oas1a and Oas1b
genes were efﬁciently upregulated by IFN beta and WNV infection
in pIRF-7−/− MEFs. These data suggest that neither IRF-3 nor IRF-7
alone is required for the upregulation of these ISGs in WNV Eg101-
infected MEFs. The more efﬁcient upregulation of the tested ISGs in
cells deﬁcient in IRF-3 or IRF-7 compared to the wild type control
cells suggested the possibility that these two transcription factors
may be involved in a negative feedback mechanism of ISG regulation.
Since the combination of IRF-3 and IRF-7 was previously reported to
be required for robust production of type I IFN as well as for the in-
duction of ISGs such as ISG54, ISG49 and RIG-I in MEFs infected
with WNV NY 2000 (Dafﬁs et al., 2009), the induction of Oas1a and
Oas1b expression was also analyzed in pIRF-3/7−/−MEFs. Although
Oas1a and Oas1b expression was upregulated to similar levels in con-
trol and pIRF-3/7−/−MEFs at 8 and 16 h after WNV Eg101 infection,
a decrease in Oas1a and Oas1b mRNA levels compared to that in con-
trol cells was observed at 24 and 32 h after infection suggesting that
at least one of these TFs is needed to enhance the upregulation of
these ISGs at later times of infection. Irf1 upregulation by WNV
Eg101 infection was similar in pIRF-3/7−/− and control MEFs
(Fig. 5D). Irf9 mRNA levels were also assessed in pIRF-3/7−/− MEFs.
Irf9 was upregulated to similar levels in WNV Eg101-infected controlEFs. Fold increase in (A) Oas1a, (B) Oas1b, (C) Irf7 mRNA, (D) Irf1 and (E) Irf9 expres-
al-time qRT-PCR. Each qRT-PCR experiment was performed in triplicate and represen-
of each gene was normalized to the level of GAPDH mRNA in the same sample and is
he error bars represent the calculated SE (n=3) and are based on an RQMin/Max of the
analyzed for infectivity by plaque assay. Each data point is the average of duplicate ti-
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in pIRF-3−/− and pIRF-7−/−MEFs as in wild type cells but the pIRF-
3/7−/−MEFs produced higher yields of virus (Fig. 5F).
The induction of Irf7, Irf1 and Oas1a gene expression by poly(I:C)
was previously shown to be blocked in IRF-3/9−/− MEFs (DeWitte-
Orr et al., 2009). To test whether the expression of these ISGs is in-
duced by WNV Eg101 infection in the absence of IRF-3 and IRF-9,
pIRF-3/9−/− MEFs were infected with WNV Eg101 (MOI 5) for 8,
16, 24 or 32 h and Oas1a, Oas1b, Irf7 and Irf1 mRNA levels were
assayed by real time qRT-PCR. No signiﬁcant upregulation of Oas1a,
Oas1b or Irf7 expression was observed in these knockout cells
(Figs. 6A, B and C). Since IRF-3 was shown not to be required for
ISG upregulation in WNV infected MEFs, the data obtained with the
pIRF-3/9−/− MEFs suggested that IRF-9 was required. Irf1 expres-
sion was upregulated in pIRF-3/9−/− MEFs to the same or higher
levels than in control MEFs (Fig. 6D) indicating that this gene is upregu-
lated in infected cells by a different set of TFs than those regulating
Oas1a, Oas1b and Irf7 gene expression. Analysis of the WNV Eg101
yields produced by control and pIRF-3/9−/− MEFs indicated that
virus replication was more efﬁcient in the pIRF-3/9−/−MEFs (Fig. 6E).
Previous studies reported that a WNV infection is sensed by the
cytoplasmic RNA sensors RIG-I and MDA5 (Fredericksen and Gale,
2006; Fredericksen et al., 2008) and that RIG-I and MDA5 play differ-
ent but redundant roles in the activation of IRF-3 and IRF-3-depen-
dent genes in WNV infected cells (Fredericksen et al., 2008; Loo
et al., 2008). Upon recognition of viral RNA, RIG-I and MDA5 interact
through their caspase activation and recruitment domains (CARDs)
with adaptor molecule promoter-stimulating factor (IPS-I) (KatoFig. 6. Irf-1, but not Oas1a, Oas1b and Irf7, is upregulated in pIRF-3/9−/− MEFs infected w
pression levels in C57BL/6 and IRF-3/9/- MEFs was assayed by real-time qRT-PCR. Each qRT-
three independent experiments are shown. The mRNA level of each gene was normalized to
amount of mRNA in mock samples expressed in RQUs. The error bars represent the calculate
harvested at the indicated times after infection was analyzed for infectivity by plaque assay.
indicate ±SD.et al., 2008; Takeuchi and Akira, 2008). A previous study showed
that IPS-1 is required for the activation of IRF-3 and the IRF-3 target
genes, ISG54 and ISG56, in WNV infected cells (Fredericksen et al.,
2008; Suthar et al., 2010). To assess the roles of RIG-I, MDA5
and IPS-1 in the induction of IRF-3 independent ISG upregulation,
pRIG-I−/−, pMDA5−/− and pIPS-1−/− MEFs were mock treated,
treated with 1000 U/ml of IFN beta or infected with WNV Eg101 at
a MOI of 5 and the Oas1a, Oas1b, Irf7 and Irf1 mRNA levels were
assayed by real time qRT-PCR (Figs. 7A, B, C and D). Although the
level of Oas1a, Oas1b, Irf7 and Irf1 upregulation was similar in WNV
infected pRIG-I−/− and control pC57BL/6 MEFs, the expression of
these ISGs in infected pMDA5−/− MEFs was lower suggesting that
MDA5 signaling plays a more important role in ISG upregulation in
WNV infected MEFs. At 8 h after infection, Oas1a was upregulated
to similar levels in control and pIPS-1−/− MEFs while the upregula-
tion of Oas1b and Irf7 was lower in infected pIPS-1−/−MEFs than in
control cells. However, the mRNA levels of all three of these ISGs de-
creased progressively at later times after infection. No signiﬁcant upre-
gulation of Irf1 was observed in infected pIPS-1−/− MEFs at 8 h. A
small increase in Irf1 upregulation was observed at 16 h but the
mRNA levels decreased at later times. The data indicate that IPS-1 is
only partially involved in the initial induction of IRF-3-independent
ISGs in WNV infected cells but is required for gene expression at later
times after infection. Only minimal upregulation of the IFN beta
gene was observed in either IFN beta treated or WNV infected
pIPS-1−/−MEFs (Fig. 7E). HigherWNV Eg101 yields were produced
by pIPS-1−/− MEFs than by pRIG-I−/−, pMDA5−/− or matched
wild type MEFs (Fig. 7F).ith WNV Eg101. Fold increase in (A) Oas1a, (B) Oas1b, (C) Irf7 and (D) Irf1 mRNA ex-
PCR experiment was performed in triplicate and representative data from one of two or
the level of GAPDHmRNA in the same sample and is shown as the fold change over the
d SE (n=3) and are based on an RQMin/Max of the 95% conﬁdence level. (E) Culture ﬂuid
Each data point is the average of duplicate titrations from at least two experiments. Bars
Fig. 7. IPS-1 is involved in regulating the expression of Oas1a, Oas1b, Irf7 and Irf1 in MEFs infected with WNV Eg101. Fold increase in (A) Oas1a, (B) Oas1b, (C) Irf7, (D) Irf1 and (E)
IFN beta mRNA expression levels in pC57BL/6, pRIG-I−/−, pMDA5−/− and pIPS-1−/−MEFs was assayed by real-time qRT-PCR. Each qRT-PCR experiment was performed in triplicate
and representative data fromone of two or three independent experiments are shown. ThemRNA level of each genewas normalized to the level of GAPDHmRNA in the same sample and
is shown as the fold change over the amount of mRNA in mock samples expressed in RQUs. The error bars represent the calculated SE (n=3) and are based on an RQMin/Max of the 95%
conﬁdence level. (F) Culture ﬂuid harvested at the indicated times after infectionwas analyzed for infectivity by plaque assay. Each data point is the average of duplicate titrations from at
least two experiments. Bars indicate ±SD.
90 J.A. Pulit-Penaloza et al. / Virology 425 (2012) 82–94Discussion
Activation of ISGs by type 1 IFN ismediated by the ISGF3 TF complex
composed of STAT1, STAT2 and IRF-9. STAT1 and STAT2 proteins pri-
marily reside in the cytoplasm and the formation and nuclear transloca-
tion of the ISGF3 complex depend on IFN-mediated phosphorylation of
STAT1 on Tyr701 and STAT2 on Tyr690 (Qureshi et al., 1996; Schindler
et al., 1992; Shuai et al., 1992).Most viruses, includingﬂaviviruses, have
evolved mechanisms to suppress the type 1 IFN pathway. The lineage I
WNV strains TX02 and NY99 inhibit STAT1 and STAT2 nuclear translo-
cation by blocking phosphorylation of these proteins in primate cells
and theWNVNY99NS5 proteinwas shown tomediate this suppression
(Keller et al., 2006; Laurent-Rolle et al., 2010). In contrast, the attenuat-
ed lineage I strain, Kunjin, is a poor suppressor of STAT1 phosphoryla-
tion due to a single NS5 mutation, Phe653Ser (Laurent-Rolle et al.,
2010). Eg101 and NY99 are closely related lineage I viruses but Eg101
it is less neuroinvasive (Beasley et al., 2002). The WNV Eg101 NS5 has
a Phe at position 653 and blocks STAT phosphorylation in primate
cells (Scherbik and Brinton, unpublished data). In contrast, WNV
Eg101 infections did not block STAT1 phosphorylation at Tyr701 or
STAT2 phosphorylation of Tyr690 in MEFs. A decrease in STAT2 phos-
phorylation was only observed at 48 h. These results indicate that
there are host species speciﬁc differences in the ability of WNV to sup-
press STAT phosphorylation. How a WNV Eg101 infection preventsnuclear translocation of phospho-STAT1 and phospho-STAT2 in MEFs
is currently under investigation. The dengue virus NS5 proteinwas pre-
viously reported to bind to and target human STAT2 for degradation but
was not able tomediate the degradation ofmurine STAT2 (Ashour et al.,
2010). No evidence of either STAT1 or STAT2 degradationwas observed
in WNV Eg101-infected MEFs.
Activation of the Oas1a, Oas1b, Irf7 and Irf1 genes was previously
reported to be IRF-3-independent (Andersen et al., 2008; Nakaya
et al., 2001) and the Oas1a and Irf7 genes were reported to be activat-
ed only by canonical type I IFN signaling (Nakaya et al., 2001). Data
from the present study indicated that upregulation of Oas1a, Oas1b,
Irf7 and Irf1 occurred by a STAT1-, STAT2- and type I IFN-
independent regulatory mechanism in WNV Eg101-infected MEFs.
Although the activation of IRF factors, such as IRF-3 and IRF-7, by
viral infections was previously reported to mediate IFN-independent
upregulation of subsets of ISGs, the Oas1a, Oas1b, Irf7 and Irf1genes
were efﬁciently upregulated by WNV Eg101 infection in IRF-3−/−
MEFs and the Oas1a, Oas1b, and Irf1 gene expression were efﬁciently
activated in IRF-7−/− MEFs indicating that neither IRF-3 nor IRF-7
alone was sufﬁcient to induce upregulation of these genes in infected
MEFs. A previous study done withWNV NY 2000-infected IRF-3/7−/−
MEFs reported that IRF-3 or IRF-7 was necessary for production of type
I IFN and induction of ISGs such as ISG54, ISG49 and RIG-I (Dafﬁs et al.,
2009).We observed only a very low level of IFN beta gene upregulation
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there was a 27 fold increase in IFN beta mRNA levels compared to an
8000 fold increase in wild type MEFs (data not shown). In contrast, ef-
ﬁcient induction of the Oas1a, Oas1b, Irf7 and Irf1 genes was observed
in IRF-3/7−/−MEFs infected for 8 and 16 h withWNV Eg101. Howev-
er, the absence of both IRF-3 and IRF-7 reduced the levels of Oas1a and
Oas1b expression at later times of infection suggesting that at least one
of these IRFs is needed to enhance and sustain the upregulation of
these two ISGs. No Oas1a and Oas1b upregulation was observed in
IRF-3/9−/− MEFs and the expression of Irf7 was also not upregulated
in these cells. These observations together with the observation that
Irf9 was upregulated in infected IRF-3/7−/− MEFs suggest the possi-
bility that IRF-9 is involved in the initial upregulation of these ISGs in
WNV Eg101-infected cells. Since IRF-9 cannot transactivate gene ex-
pression alone (Kraus et al., 2003), it must interact with additional
partners to activate ISG expression in MEFs infected with WNV
Eg101. However, it is not currently known whether IRF-9 can form
complexes with as yet unidentiﬁed TF(s) and/or whether IRF-9 can in-
teract with IRF-3 or IRF-7 to upregulate a subset of ISGs inWNV Eg101-
infected MEFs.
IRF-1 was originally described as a TF involved in the induction of
the IFN-alpha and IFN-beta genes (Miyamoto et al., 1988). However,
it can also upregulate the expression of some ISGs in an IFN-
independent manner (Schoggins et al., 2011). Overexpression of Irf1
was recently shown to inhibit the replication of WNV, dengue virus,
yellow fever virus, hepatitis C virus, Chikungunya virus, Venezuelan
encephalitis virus and human immunodeﬁciency virus I (Schoggins
et al., 2011). One of the IRF-1 target genes, viperin, (Stirnweiss et
al., 2010) was reported to inhibit both WNV and dengue virus infec-
tions (Jiang et al., 2010). In a previous study from our lab, the kinetics
of upregulation of multiple ISGs in primary C3H/He MEFs infected
with WNV Eg101 was analyzed (Scherbik et al., 2007). ISGs such as
Oas1a, Oas1b and Irf7 were efﬁciently upregulated by WNV Eg101
at early times after infection while the upregulation of a subset of
ISGS including Irf1 was delayed. The Irf1 gene promoter contains a
GAS element instead of an ISRE and upregulation of this gene by
type I and type II IFNs is dependent on STAT1 dimers rather than
the ISGF3 TF complex (Pine et al., 1994). The murine Irf1 gene was
previously reported to be activated in an IRF-3-independent manner
(Andersen et al., 2008). However, another study reported that Irf1
upregulation by poly(I:C) was blocked in IRF-3/9−/− MEFs
(DeWitte-Orr et al., 2009). The results of the present study indicate
that the upregulation of Irf1 gene expression in WNV Eg101-infected
MEFs is mediated in an IRF-3-, IRF-9- and IRF-7-independent manner.
An Irf1 promoter analysis predicted the presence of NF-kappa B binding
sites (Harada et al., 1994; Pine et al., 1994) and Irf1 gene expressionwas
previously reported to be induced by this TF (Pahl, 1999). NF-kappa B is
activated by a WNV Eg101-infection in MEFs (Scherbik et al., unpub-
lished results) and the involvement of NF-kappa B components in regu-
lating Irf1 upregulation in infected cells is currently under investigation.
During a WNV infection, viral RNA is recognized by RIG-I and
MDA5 cytoplasmic sensors (Fredericksen et al., 2008) which signal
through the IPS-1 adaptor molecule to activate IRF-3 leading to the
induction of IFN and IRF-3-dependent gene expression (Dafﬁs et al.,
2009; Fredericksen et al., 2008; Suthar et al., 2010). The results of
the present study showed that lack of MDA5 but not of RIG-I resulted
in a reduction in Oas1a, Oas1b, Irf7 and Irf1 upregulation suggesting
that MDA5 may be functionally more important for the activation of
these genes in WNV infected MEFs. In addition, the results of this
study showed that the initial upregulation of Oas1a, Oas1b and Irf7
but not of Irf1 in WNV Eg101infected MEFs is only partially depen-
dent on IPS-1 since the mRNA levels of these genes were upregulated
in IPS-1 deﬁcient cells at 8 h after infection. The lack of induction of
IFN beta gene expression at 8 h after infection in IPS-1−/−MEFs con-
ﬁrmed that the upregulation of these genes was independent of IFN-
beta. The mechanism by which the initial IFN- and IPS-1-independentupregulation of a subset of ISGs occurs is currently not known. Early
induction of ISGs may be due to activation of signaling pathways by
WNV entry. The existence of such a response to virus particle entry
was previously reported and shown to be IFN-, TLR- and RIG-I inde-
pendent (Paladino et al., 2006). The interaction of the fusion peptides
of enveloped viruses with cellular membranes was also shown to ac-
tivate several cell transduction pathways leading to early activation of
ISGs by AP-1 and NF-kappa B (Vitiello et al., 2010). However, IPS-1
was required for ISG expression at later times of WNV infection.
The higher viral loads in tissues and increased mortality observed
with WNV NY99-infected IFN alpha/beta R−/− and IFN beta−/−
mice indicate the importance of the type I IFN response for host pro-
tection (Lazear et al., 2011; Samuel and Diamond, 2005). Type I IFN
secreted by infected cells induces an antiviral state in uninfected
cells through the induction of ISGs and this reduces viral spread.
The upregulation of ISGs by IFN-independent mechanisms in infected
cells would be expected to reduce virus yields even though canonical
IFN signaling was blocked by the infection in these cells. It was previ-
ously shown that IRF-3-dependent ISGs could be upregulated in
WNV-infected cells and experiments in IRF-3−/− mice indicated
that IRF-3 protected mice by both IFN-dependent and IFN-
independent mechanisms (Dafﬁs et al., 2007; Fredericksen et al.,
2004). IRF-7 was shown to protect mice primarily through the induc-
tion of IFN alpha (Dafﬁs et al., 2008). The data obtained in the present
study indicate that there are additional mechanisms of IFN-
independent ISG upregulation for subsets of ISGs in infected MEFs
and that IFN-independent ISG upregulation is more complex than
previously appreciated. The data also suggest that IRF-9 may be in-
volved in both IFN-dependent as well as IFN-independent activation
complexes for some ISGs.Materials and methods
Cells and viruses
SV40-T antigen transformed C3H/He (tC3H/He) MEFs were grown
in minimal essential medium (MEM) supplemented with 5% fetal bo-
vine serum (FBS) and 10 μg/ml gentamicin. Primary C3H/He MEFs
(pC3H/He), pIRF-3−/−, pIRF-7−/− and pC57BL/6 MEFs (provided
by Michael Diamond, Washington University School of Medicine, St.
Louis, MO) were grown in Dulbecco's modiﬁed Eagle's media
(DMEM) supplemented with 10% FBS and 10 μg/ml gentamicin.
pIRF-3/7−/−MEFs (provided by Michael Diamond, Washington Uni-
versity School of Medicine, St. Louis, MO) were grown in Dulbecco's
modiﬁed Eagle's media (DMEM) supplemented with 15% FBS, non-
essential amino acids (NEAA) and 1% PenStrep (Gibco). pRIG-I−/−,
pMDA5-1−/−, pIPS-1−/− and matched pC57BL/6 MEFs (provided
by Michael Gale, University of Washington, Seattle, WA) were
grown in DMEM supplemented with 10% FBS, NEAA, and 1X antibiotic/
antimycotic (Invitrogen). t129/SvEv, tSTAT1−/− and tSTAT2−/− MEF
cell lines (provided by Christian Schindler, Columbia University,
New York, NY) were grown in MEM supplemented with 10% FBS and
1% PenStrep. p129 MEFs and pIFN alpha/beta R−/−MEFs (provided by
Herbert Virgin, Washington University School of Medicine, St. Louis,
MO)were grown inDMEMsupplementedwith 10% FBS and 1% PenStrep.
pIRF-3/9−/−MEFs (provided by Karen Mossman, McMaster University,
Hamilton, Ontario, Canada) were grown in MEM alpha supplemented
with 10% FBS and 1% PenStrep. All cell cultures were grown at 37 °C in a
5% CO2 atmosphere.
A stock of lineage I WNV strain Eg101 was prepared by infecting
BHK cells (Vaheri et al., 1965) grown in MEM supplemented with
5% FBS and 10 μg/ml gentamicin at a MOI of 0.1 and harvesting cul-
ture ﬂuid 32 h after infection, a time when the infected cell monolay-
er was still intact. Clariﬁed culture ﬂuid was aliquoted and stored at
−80 °C. The titer of the stock virus was ~1×108 PFU/ml.
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Cell culture ﬂuid was collected at various times after WNV Eg101
infection and the levels of secreted IFN beta protein in these samples
were assessed by a capture ELISA according to the manufacturer's in-
structions (PBL Biomedical Laboratories, NJ) using a standard curve
prepared by titrating a known concentration of recombinant murine
IFN beta.
ChIP
Conﬂuent tC3H/He monolayers were mock-infected, infected with
WNV Eg101 at a MOI 5 for 7, 16 or 24 h or treated with 1000 U/ml of
murine IFN beta for 30 m. In pilot experiments, the levels of TFs
bound to the tested ISG promoters were found to be consistently
higher at 30 m than at 3 h after IFN treatment. The ChIP assay was
done as previously described (Pulit-Penaloza et al., 2012). Isolated
DNA was analyzed by real-time PCR using probes and primers
designed to span the proximal Oas1a and Oas1b promoters. The
sequences of the primers were: Oas1a forward primer 5′-GGATCC-
TAAGAAAGCTCAGACTTCA-3′, Oas1a reverse primer 5′-CCCGGCAGC-
CAATGG-3′, Oas1b forward primer 5′-GAAGCCCTAACGCCATTGG-3′,
Oas1b reverse primer 5′-AGGGCGCGGATATGCA-3′, Irf7 forward
primer 5′-CCTGCCTTGTCCCAATGTG-3′ and Irf7 reverse primer 5′-
ACACCCGACCCTTACTCAGATC-3′ and Irf1 forward primer 5′-CC-
TTCGCCGCTTAGCTCTAC-3′ and Irf1 reverse primer 5′-CCCAC-
TCGGCCTCATCATT-3′. The sequence of the FAM-MGB Oas1a probe
was 5′-TGGAAGTGTGGGAAAGGTCTTT-3′, that of the Oas1b probe
was 5′-CGGGCCTGGATGAT-3′ that of the Irf7 probe was 5′-
TTTCCTGAAGAGGTCCTG-3′ and that of Irf-1 probe was 5′-ACAGCCT-
GATTTCC-3′. To obtain standard curves, known amounts of Oas1a,
Oas1b and Irf7 and Irf1 promoter DNA cloned into a TOPO-XL vector
(Invitrogen) were titrated and assayed by real-time quantitative
PCR (qPCR) using a FastStart Universal Probe Master (ROX) kit
(Roche Applied Science) according to the manufacturer's protocol.
To quantify the immunoprecipitated DNA, standard curves were in-
dependently generated at the same time as the immunoprecipitated
DNA samples by qPCR and the value of the fold change over the
value obtained with a mock-infected sample was calculated. The av-
erage values from at least two independent experiments were plot-
ted. Bars represent ±SD.
Quantiﬁcation of mRNA levels
Real-time quantitative reverse transcription-PCR (qRT-PCR) ana-
lyses of mouse Oas1a and Oas1b gene expression were performed
using a 50 μl reaction mixture containing 500 ng of total cellular
RNA, a primer pair (1 μM), a probe (0.2 μM) and an Applied Biosys-
tems 7500 Sequence Detection System. Applied Biosystems Assays-
on-Demand 20× primer and ﬂuorogenic TaqMan FAM/MGB probe
mixes Mn00836412_m1 for Oas1a, Mn00449297_m1 for Oas1b,
Mn00516788_m1 for Ifr7 and Mn01288580_m1 for Irf1 were used.
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was
used as an endogenous control for each sample and was detected
using TaqMan mouse GAPDH primers and probe (Applied Biosys-
tems). One-step RT-PCR was performed for each target gene and for
the endogenous control in a singleplex format using 200 ng of RNA
and the TaqMan One-Step RT-PCR Master Mix Reagent Kit (Applied
Biosystems). The cycling parameters were as follows: reverse tran-
scription at 48 °C for 30 m, AmpliTaq activation at 95 °C for 10 m, de-
naturation at 95 °C for 15 s, and annealing/extension at 60 °C for 1 m
(cycle repeated 40 times). Each experiment was repeated at least two
times in triplicate. Triplicate Ct values were analyzed with Microsoft
Excel using the comparative Ct (ΔΔCt) method of the SDS Applied
Biosystems software which also applied statistical analysis to the
data (TINV test in Microsoft Excel). The values were normalized tothose for GAPDH and presented as the relative fold change compared
to the uninfected calibrator sample in relative quantiﬁcation units
(RQUs). Error bars represent the standard error of the mean (SE)
and indicate the calculated minimum (RQMin) and maximum
(RQMax) of the mRNA expression levels based on a RQMin/Max of the
95% conﬁdence level. The expression levels between two samples
were considered statistically different (P value of b0.05) when the
error bars did not overlap.
Confocal immunoﬂuorescence microscopy
tC3H/He MEFs grown to 50% conﬂuency on 15-mm glass cover-
slips in 12-well plates were infected with WNV Eg101 at a MOI of 5.
The cells were ﬁxed with 4% paraformaldehyde in PBS for 10 min at
RT and then permeabilized with 0.1% Triton X-100 in PBS for
10 min. Coverslips were washed with PBS, blocked overnight in 5%
heat-inactivated horse serum (Invitrogen) in PBS, and then incubated
with mouse anti-dsRNA antibody (English and Scientiﬁc Consulting,
Hungary) diluted 1:500 in the blocking buffer or with rabbit anti-
STAT2 antibody (generously provided by Christian Schindler, Colum-
bia University, New York, NY) diluted 1:200 for 1 h at room temper-
ature. The coverslips were washed three times with PBS and
incubated with donkey anti-mouse Alexa Fluor 594 or donkey anti-
rabbit Alexa Fluor 488 secondary antibodies (Invitrogen) diluted
1:400 in blocking buffer containing 0.5 μg/ml of Hoechst 33342 dye
(Invitrogen). The coverslips were washed with PBS and mounted on
glass slides with Prolong Gold Antifade reagent (Invitrogen). Cells
were visualized with a 40× oil-immersion objective on a LSM 700
laser confocal microscope (Zeiss, Oberkochen, Germany) using LSM
5 (version 4.2) software (Carl Zeiss Inc.). All of the images compared
were obtained using the same instrument settings.
Western blotting
Whole tC3H/He cell extracts were prepared using radioimmuno-
precipitation assay buffer [1× PBS, 1% Nonidet P-40, 0.5% sodium
deoxycholate, and 0.1% SDS containing Halt Protease and Phospha-
tase Inhibitor Single-Use Cocktail (Thermo Scientiﬁc)]. t129 MEF
and STAT2−/−MEF nuclear and cytoplasmic extracts were prepared
using a Nuclear Extract kit (Active Motif) according to the manufac-
turer's protocol. Following separation by SDS-polyacrylamide gel
electrophoresis (PAGE), the proteins were electrophoretically trans-
ferred to a nitrocellulose membrane. The membrane was blocked
with Tris-buffered saline pH 8, containing 5% dry milk (5% bovine
serum albumin was substituted for milk when phosphorylated pro-
teins were detected) and 0.1% Tween-20 for 1 h at 22 °C and then in-
cubated with a polyclonal primary antibody speciﬁc for: STAT1 (Cell
Signaling), phospho-STAT1 (Tyr701) (Cell Signaling), STAT2 (provid-
ed by Christian Schindler, Columbia University, New York, NY),
phospho-STAT2 (Tyr 690) (Abcam), IRF-9 (Santa Cruz Biotechnolo-
gy), WNV NS3 (R&D Systems) or beta-actin (Abcam) overnight at
4 °C in the presence of blocking buffer. The blots were then incubated
with anti-rabbit antibody conjugated with horseradish peroxidase
(Santa Cruz Biotechnology) or anti-mouse antibody conjugated with
horseradish peroxidase (Cell Signaling) for 1 h at 22 °C and processed
for enhanced chemiluminescence using a Super-Signal West Pico de-
tection kit (Thermo Scientiﬁc) according to the manufacturer's
instructions.
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